Cargando…

Expanding the role of combined immunochemotherapy and immunoradiotherapy in the management of head and neck cancer (Review)

Immunotherapy has become one of the most promising approaches in tumor therapy, and there are numerous associated clinical trials in China. As an immunosuppressive tumor, head and neck squamous cell carcinoma (HNSCC) carries a high mutation burden, making immune checkpoint inhibitors promising candi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Chun, Lan, Xiaojun, Qiu, Maona, Cui, Ran, Fu, Qiuxia, Shinge, Shafiu A. Umar, Muluh, Tobias Achu, Jiang, Ou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641411/ https://www.ncbi.nlm.nih.gov/pubmed/37965160 http://dx.doi.org/10.3892/ol.2023.13958

Ejemplares similares

Mechanosensitive Piezo1 Channel Evoked-Mechanical Signals in Atherosclerosis
por: Shinge, Shafiu A Umar, et al.
Publicado: (2021)

Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma
por: Leidner, Rom, et al.
Publicado: (2021)

IL-2 complex recovers steroid-induced inhibition in immunochemotherapy for head and neck cancer
por: Kono, Michihisa, et al.
Publicado: (2022)

Emerging Piezo1 signaling in inflammation and atherosclerosis; a potential therapeutic target
por: Shinge, Shafiu A. Umar, et al.
Publicado: (2022)

Combination of CAR‑T cell therapy and radiotherapy: Opportunities and challenges in solid tumors (Review)
por: Zhong, Liqiang, et al.
Publicado: (2023)

Immunoradiotherapy as an Effective Therapeutic Strategy in Lung Cancer: From Palliative Care to Curative Intent
por: Chicas-Sett, Rodolfo, et al.
Publicado: (2020)

Comparison of Pneumonitis Rates and Severity in Patients With Lung Cancer Treated by Immunotherapy, Radiotherapy, and Immunoradiotherapy
por: Aiad, Mina, et al.
Publicado: (2022)

Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejection
por: Hu, Yun, et al.
Publicado: (2023)

Combination immunochemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: a systematic review and meta-analysis
por: Xu, Qiudong, et al.
Publicado: (2023)

Diverse effects of chemotherapeutic agents on immune cell function and implications in immunochemotherapy
por: Glorieux, Christophe, et al.
Publicado: (2021)

Identification of CXCL10-Relevant Tumor Microenvironment Characterization and Clinical Outcome in Ovarian Cancer
por: Jin, Jing, et al.
Publicado: (2021)

Effect of low-dose total-body radiotherapy on immune microenvironment
por: Chen, Zhuo, et al.
Publicado: (2021)

Radiotherapy for HPV-related cancers: prediction of therapeutic effects based on the mechanism of tumor immunity and the application of immunoradiotherapy
por: Someya, Masanori, et al.
Publicado: (2022)

Low dose novel PARP-PI3K inhibition via nanoformulation improves colorectal cancer immunoradiotherapy
por: Landry, M.R., et al.
Publicado: (2020)

Efficacy and safety of immunoradiotherapy for advanced non-small cell lung cancer: a retrospective comparative cohort study
por: Gao, Yifan, et al.
Publicado: (2023)

Current trends of anticancer immunochemotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Bacteria in cancer therapy: A new generation of weapons
por: Fan, Jun Ying, et al.
Publicado: (2022)

Trial Watch: Lenalidomide-based immunochemotherapy
por: Semeraro, Michaela, et al.
Publicado: (2013)

Immunochemotherapy for Richter syndrome: current insights
por: Puła, Bartosz, et al.
Publicado: (2019)

Immunotherapy and immunochemotherapy in combating visceral leishmaniasis
por: Yadagiri, Ganesh, et al.
Publicado: (2023)

Bifidobacterium in anticancer immunochemotherapy: friend or foe?
por: Procaccianti, Giorgia, et al.
Publicado: (2023)

Enhancing Cancer Immunotherapy Treatment Goals by Using Nanoparticle Delivery System
por: Muluh, Tobias Achu, et al.
Publicado: (2021)

NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model
por: Hu, Yun, et al.
Publicado: (2022)

ABC triblock bottlebrush copolymer-based injectable hydrogels: design, synthesis, and application to expanding the therapeutic index of cancer immunochemotherapy
por: Vohidov, Farrukh, et al.
Publicado: (2020)

The expanding role of IAP antagonists for the treatment of head and neck cancer
por: Kansal, Vikash, et al.
Publicado: (2023)

Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes
por: Castellino, Alessia, et al.
Publicado: (2022)

Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer
por: Hu, Yun, et al.
Publicado: (2022)

Neoadjuvant immunochemotherapy with pembrolizumab plus chemotherapy in resectable non-small cell lung cancer
por: Chen, Yulong, et al.
Publicado: (2023)

An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy
por: Chen, Yichao, et al.
Publicado: (2016)

Hypofractionated radiotherapy with immunochemotherapy for extensive-stage small-cell lung cancer
por: Liu, Chaoyuan, et al.
Publicado: (2023)

Inorganic Nanozyme with Combined Self-Oxygenation/Degradable Capabilities for Sensitized Cancer Immunochemotherapy
por: Wang, Jie, et al.
Publicado: (2019)

Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease
por: Roatt, Bruno Mendes, et al.
Publicado: (2014)

Drug screening approach combines epigenetic sensitization with immunochemotherapy in cancer
por: Facciotto, Chiara, et al.
Publicado: (2019)

Campylobacter fetus spondylodiscitis during immunochemotherapy for non-Hodgkin's lymphoma
por: Cunha, Jéssica Santos, et al.
Publicado: (2021)

The Feasibility of Virtual Toxicity Assessments in Lymphoma Patients Receiving Immunochemotherapy
por: Runge, John S., et al.
Publicado: (2020)

Neoadjuvant PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy in Locally Advanced Anal Canal Squamous Cell Carcinoma Patients: Antitumor Efficacy, Safety and Biomarker Analysis
por: Xiao, WeiWei, et al.
Publicado: (2022)

COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma
por: Gaitzsch, Erik, et al.
Publicado: (2021)

A modified prognostic model in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
por: Zhao, Peiqi, et al.
Publicado: (2021)

Plasma extracellular vesicle transcriptomics identifies CD160 for predicting immunochemotherapy efficacy in lung cancer
por: Liao, Jiatao, et al.
Publicado: (2023)

Insured persons dilemma about other family members: a perspective on the national health insurance scheme in Nigeria
por: Umar, Nasir, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_di06m5t5cldho4s1jr1g4dpg3p